Formulation Development White Papers & Articles
-
5 Trends Impacting CMOs In 2025
2/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge
2/3/2025
The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.
-
How Oral GLP-1 Therapies Are Revolutionizing Obesity Treatment
2/3/2025
The rising incidence and severity of obesity have amplified a therapeutic need in healthcare. Read more about Dr. Srinivasan Shanmugam discussing the challenges and impact of GLP-1 analogs.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Futurizing Healthcare By Localizing The Life Sciences
12/12/2024
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
-
The Rise Of Complex OSD Generics: Understanding Development Challenges
12/11/2024
Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
12/10/2024
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Expanding Translational Research Concepts With Genedata Profiler
11/26/2024
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
-
Digital And AI Solutions With The Life Sciences Companies Of Danaher
11/26/2024
Explore how life sciences solutions integrate advanced technologies and AI to accelerate drug discovery, and streamline workflows for innovative biopharmaceutical research and development.
-
Nose To Brain (N2B) Drug Delivery – Benefits And Challenges
11/20/2024
Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).